Biogen Reports 2016 Revenues of $11.4 Billion
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Biogen (BIIB) Tops Q4 EPS by 8c; FY17 Rev Guidance Falls Below the Street
January 26, 2017 6:32 AM ESTBiogen (NASDAQ: BIIB) reported Q4 EPS of $5.04, $0.08 better than the analyst estimate of $4.96. Revenue for the quarter came in at $2.87 billion versus the consensus estimate of $2.94 billion.
GUIDANCE:
Biogen sees FY2017 EPS of $20.45-$21.45, versus the consensus of $21.02. Biogen sees FY2017 revenue of $11.1-11.4 billion, versus the consensus of $12.07 billion.
"
Biogen seeks to advance transformational... More
